Quick-Med to present abstracts on antimicrobial technologies at Clinical Symposium

Sep 29 2010

Quick-Med Technologies, Inc. (OTCBB:QMDT), a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announced today its NIMBUS^® and Stay Fresh™ antimicrobial technologies will be highlighted at the 2010 Clinical Symposium on Advances in Skin and Wound Care, to be held in Orlando, Florida from September 30 – October 3, 2010.

NIMBUS and Stay Fresh are part of Quick-Med's suite of technologies aimed at infection control and prevention. At the symposium, Quick-Med will present two abstracts on its recent studies of both technologies.

NIMBUS^® Advanced Active, a new prototype wound dressing, will be featured in the first abstract entitled, "Improved Healing in Tissue Culture Model of Vesicant Injury Shown by High Feature Antimicrobial Dressing." Results of NIMBUS^® Advanced Active demonstrated significant wound healing improvements in chemically injured human tissue.

Quick-Med's Stay Fresh textiles technology is the subject of the second abstract entitled, "Antifungal and Antibacterial Textiles to Interrupt Pathogen Transfer." Results support the efforts of Quick-Med Technologies to develop Stay Fresh textile treatments that provide durable and highly effective bacterial and fungal control, to help prevent Hospital Acquired Infections (HAIs).

"I am excited to present these abstracts on the unique technologies NIMBUS Advanced Active and Stay Fresh," said Dr. Bernd Liesenfeld, Senior Scientist of Quick-Med. "Derived from Quick-Med's FDA-approved NIMBUS technology, NIMBUS Advanced Active is shown to significantly enhance wound healing. It is the ultimate multi-functional dressing, with applicability for acute and chronic wounds."